Uptravi 60 Tabs 400 mcg
60 Tabs — 400 mcg
Uptravi (selexipag) is used to treat pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs. It works by widening and relaxing the blood vessels in the lungs, which helps improve symptoms such as shortness of breath and fatigue.
- Active ingredient: Selexipag
Uptravi is a revolutionary new product that helps patients living with pulmonary arterial hypertension (PAH) manage their disease more effectively. It is a once-daily, oral medication that has been proven to significantly improve exercise capacity and reduce symptoms of PAH in adults. Uptravi has been designed to target the underlying cause of PAH, which is an abnormal narrowing of the pulmonary arteries that can lead to high blood pressure in the lungs. With Uptravi, patients can enjoy improved breathing and an increased ability to exercise, helping them to lead a more active and healthy lifestyle. Its convenient, once-daily dosage makes Uptravi easy to remember and adhere to, and it can be taken with or without food. Uptravi is an innovative and effective way to help people with PAH take control of their health and live life to its fullest.